BeiGene (NASDAQ:BGNE) Receives New Coverage from Analysts at Jefferies Financial Group
Equities researchers at Jefferies Financial Group started coverage on shares of BeiGene (NASDAQ:BGNE – Get Free Report) in a research report issued on Thursday, MarketBeat.com reports. The firm set a “buy” rating and a $287.00 price target on the stock. Jefferies Financial Group’s price objective points to a potential upside of 49.22% from the company’s […]